Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 217.98 | 242.45 | 221.01 | 192.34 | 161.09 |
Total Expenses | 188.11 | 204.18 | 194.37 | 170.47 | 151.68 |
Profit Before Tax | 29.87 | 34.81 | 26.64 | 21.87 | 9.41 |
Profit After Tax | 22.46 | 26.72 | 18.86 | 17.06 | 7.87 |
Operating Profit after Depreciation | 30.68 | 38.68 | 26.93 | 22.39 | 9.93 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 9.30 | 24.28 | 22.60 | 25.72 | 24.44 |
Total Non Current Assets | 17.82 | 30.39 | 55.14 | 43.73 | 52.04 |
Total Current Assets | 199.25 | 164.56 | 109.08 | 120.48 | 94.91 |
TOTAL ASSETS | 217.08 | 194.95 | 164.22 | 164.20 | 146.95 |
Total Shareholder's Fund | 187.40 | 158.89 | 132.76 | 121.93 | 111.03 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 35.17 | 46.66 | 6.91 | 28.22 | 11.25 |
Net Cash used in Investing Activities | -24.55 | -57.67 | -25.78 | -2.26 | -10.76 |
Net Cash used in Financing Activities | -8.91 | -0.46 | -17.55 | -6.83 | -0.94 |
No data available
Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
---|---|---|---|---|---|
Total Revenue | 74.03 | 74.69 | 61.44 | 43.49 | 47.23 |
Total Expenses | 58.19 | 58.41 | 51.20 | 40.82 | 43.84 |
Profit Before Tax | 38.67 | 15.36 | 7.10 | 4.54 | 5.27 |
Profit After Tax | 31.99 | 11.46 | 5.33 | 3.55 | 3.96 |
Operating Profit after Depreciation | 18.16 | 17.93 | 11.68 | 5.16 | 5.91 |
₹5/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Jagsonpal Pharmaceuticals Ltd | ₹212.80 | ₹1,412.25 |
Sun Pharmaceuticals Industries Ltd | ₹1,613.65 | ₹3,87,168.69 |
Divis Laboratories Ltd | ₹5,725.20 | ₹1,51,986.07 |
Cipla Ltd | ₹1,463.25 | ₹1,18,174.12 |
Torrent Pharmaceuticals Ltd | ₹3,028.40 | ₹1,02,490.21 |
Mankind Pharma Ltd | ₹2,337.05 | ₹96,421.67 |
17 Feb 2025, 12:41 pm
Jagsonpal Pharmaceuticals rallied 3.37% to Rs 236.95 after the company's net profit zoomed 707.8% to Rs 31.99 crore in Q3 FY25 as against Rs 3.96 crore posted in Q3 FY24.
23 Jan 2025, 12:45 pm
On 22 January 2025
16 Jan 2025, 09:58 am
06 Dec 2024, 09:48 am
On 23 October 2024
17 Oct 2024, 12:13 pm